ARCHIVES

Phase IIb Trial of Vintafolide-Docetaxel Combination Meets Primary Endpoint of Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 37 No. 3 | March 28, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI, OMB Heading For November Confrontation Over Hawaii, Papanicolaou Construction Funds

October 17, 1975

NCI Formaldehyde Finding Criticized

March 7, 1986

Text of concept statement included in this 8-page issue.

July 16, 2004

Demonstration project to yield useful data, Peter Bach says.

June 3, 2005

In Brief: Carcinogenesis Task Force to Wrap Up Review In Four-Six Weeks; UCLA Groundbreaking Set

October 28, 1977

In Brief: NCI Authorization Should be $1.3 Billion, Humphrey Tells Kennedy; GOG Gets New Life

March 3, 1978